Frontiers in Cardiovascular Medicine (Dec 2023)

Comparative treatment outcomes of a single long stent vs. overlapped short stents in acute myocardial infarction

  • Doo Hwan Lee,
  • Doo Hwan Lee,
  • Doo Hwan Lee,
  • Seok Oh,
  • Seok Oh,
  • Min Chul Kim,
  • Min Chul Kim,
  • Min Chul Kim,
  • Doo Sun Sim,
  • Doo Sun Sim,
  • Doo Sun Sim,
  • Young Joon Hong,
  • Young Joon Hong,
  • Young Joon Hong,
  • Ju Han Kim,
  • Ju Han Kim,
  • Ju Han Kim,
  • Youngkeun Ahn,
  • Youngkeun Ahn,
  • Youngkeun Ahn,
  • Jae Bok Han,
  • In Soo Kim,
  • Myung Ho Jeong,
  • Myung Ho Jeong,
  • Myung Ho Jeong

DOI
https://doi.org/10.3389/fcvm.2023.1284396
Journal volume & issue
Vol. 10

Abstract

Read online

ObjectivesThere is no consensus regarding the optimal choice between single long stent (SLS) and overlapped double short stents (DSS) in patients with acute myocardial infarction (AMI). Therefore, we aimed to compare treatment outcomes among patients with AMI treated with these two different stenting methods.MethodsIn total, 537 patients with AMI from a single tertiary center were categorized into two groups: (1) those who received an SLS (stent length ≥38 mm) (n = 254; 47.3%) and (2) those who received overlapped DSS (individual stent lengths <38 mm) (n = 283; 52.7%). The primary outcome was the incidence of major adverse cardiac and cerebrovascular events (MACCEs) within 1 year.ResultsThe mean age of participants was 65.4 years, and 75.0% were male. Patients receiving an SLS had a higher rate of serum creatinine level ≥1.5 mg/dl (16.3% vs. 8.9%, p = 0.009) but a lower rate of hypertension (46.8% vs. 55.8%, p = 0.038), lesser total stent length (38.26 ± 1.31 vs. 45.20 ± 9.25 mm, p < 0.001), total procedure time (41.40 ± 15.74 vs. 53.31 ± 21.75 min, p < 0.001) and total contrast volume (134.13 ± 30.72 vs. 160.57 ± 39.77 ml, p < 0.001) than in those receiving DSS. One-year MACCEs were comparable between the two groups before [hazard ratio (HR), 1.33; 95% confidence interval (CI), 0.80–2.24] and after adjusting for covariates (HR, 1.21; 95% CI, 0.67–2.19).ConclusionsStenting with an SLS demonstrated similar outcomes compared to those achieved when using stenting with overlapped DSS in patients with AMI. Therefore, if the deliverability is acceptable, stenting with an SLS appears to be a safe and effective strategy for AMI treatment.

Keywords